Join me as I break down Cognaize's remarkable $18M funding milestone and its implications, highlighting their advancements and contributions in AI's transformative role within finance.

Join me as we delve into Meta's pioneering step towards an open innovation AI research community, analyzing its impact, potential challenges, and the buzz surrounding this bold venture.

Join me in this episode as we explore an AI model's ability to hypothesize about alien life, forecasting individuals who might pioneer groundbreaking discoveries in the quest for extraterrestrial existence.

Join this episode to explore the game-changing update of Google's Bard, unveiling its unique capability to code applications from image screenshots, potentially reshaping the future of app development with a user-friendly approach.

Join me in this episode as we analyze the uproar in Hollywood due to the strike protesting AI actor cloning, shedding light on the ensuing disruptions and the broader implications for the entertainment landscape.

Join me in this episode as we explore the much-anticipated release of CM3leon AI by Meta, discussing its revolutionary advancements, the technology behind it, and its potential to transform the future of artificial intelligence.

Join me in this episode as we delve into the disruptive effects of AI on customer service, discussing the potential elimination of 90% of jobs due to the rise of AI-powered sales calls and chatbots, and the consequential transformations in business operations.

Join this episode as we delve into Meta's announcement of a paid alternative to OpenAI's ChatGPT, examining the competitive dynamics between these AI models and the implications for user experience and market competition.

Join this episode as we explore the collaboration between the Associated Press and OpenAI, pondering the implications for journalism in an era of AI-driven news content creation.

Join us as we discuss Nvidia's significant investment of $50 million into Recursion, delving into the impact and future prospects of this collaboration focused on advancing AI in drug discovery.